In this role, he is responsible for developing an integrated approach to the company’s go-to-market model, including delivering on all strategic and financial commitments for the business, to bring the full value of Cardinal Health to its customers.
Blazejewski joined Cardinal Health in August 2017 when the company acquired Medtronic’s Patient Recovery business. He was instrumental in facilitating the purchase by Cardinal Health and had a significant impact on the success of the integration.
Prior to joining the company, Blazejewski was senior vice president and president of the global Patient Monitoring & Recovery (PMR) business, the third largest business across all of Medtronic. He led the strategy to develop solutions that improve clinical outcomes in patient conditions such as respiratory compromise, deep vein thrombosis, healthcare-acquired infection and nutritional insufficiency.
Blazejewski has nearly 25 years of sales, marketing and executive leadership experience within the medical device industry. During his tenure with Patient Recovery, the business evolved from its roots as Sherwood Medical, changing to Tyco Healthcare, Covidien and then Medtronic.
Blazejewski currently serves on the board of directors for Cardinal Health’s Political Action Committee and is the executive sponsor for the company’s Women’s Initiative Network and EMERGE development program. He also serves as an independent board director for Surgical Specialties Corporation, a privately held medical devices firm.
Blazejewski previously served on the board of directors at the Health Industry Distributors’ Association Education Foundation from 2010 to 2014, the Connecticut Business & Industry Association from 2012 to 2015, and was a member of the Massachusetts Business Roundtable from 2015 to 2017.
He is a graduate of the University of Pennsylvania with a bachelor’s degree in economics.